Viewing Study NCT02776033


Ignite Creation Date: 2025-12-25 @ 2:48 AM
Ignite Modification Date: 2026-02-28 @ 5:33 AM
Study NCT ID: NCT02776033
Status: COMPLETED
Last Update Posted: 2020-07-08
First Post: 2016-05-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 203167
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators